Tag Archives: American Diabetes Association

Avandia on Trial

The mid-July FDA advisory committee meeting to decide the fate of GlaxoSmithKline’s Avandia (rosiglitazone) is widely viewed as a test case of how the agency’s new leadership will address controversial drugs with serious risks but confusing data. A request that GSK yank its diabetes blockbuster—three years after first being associated with an increased risk of […]
Posted in Legal | Also tagged , , , , , , | Leave a comment
  • Categories

  • Meta